Amedisys Inc
NASDAQ:AMED
Amedisys Inc
Cash from Operating Activities
Amedisys Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amedisys Inc
NASDAQ:AMED
|
Cash from Operating Activities
$137.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
3%
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$13.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Amedisys Inc's Cash from Operating Activities?
Cash from Operating Activities
137.2m
USD
Based on the financial report for Dec 31, 2023, Amedisys Inc's Cash from Operating Activities amounts to 137.2m USD.
What is Amedisys Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
3%
Over the last year, the Cash from Operating Activities growth was 3%. The average annual Cash from Operating Activities growth rates for Amedisys Inc have been -22% over the past three years , -9% over the past five years , and 3% over the past ten years .